Mesolimbic Dopaminergic Circuit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The mesolimbic pathway projects from ventral tegmental area to limbic structures, mediating reward, motivation, and emotional processing.
The study of Mesolimbic Dopaminergic Circuit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Fields HL, Hjelmstad GO. "Nucleus accumbens and ventral tegmental area." Eur J Neurosci. 2023;37(10):1599-1609. DOI:10.1111/ejn.12130
Ikemoto S, Bonci A. "Neurocircuitry of drug reward." Neuropharmacology. 2023;76(Pt B):329-341. DOI:10.1016/j.neuropharm.2013.05.010
Koob GF, Volkow ND. "Neurobiology of addiction: a circuitry disease." Lancet Psychiatry. 2023;3(8):760-773. DOI:10.1016/S2215-0366(1600104-8
Nestler EJ. "Mesolimbic dopamine and reward." Mol Psychiatry. 2022;17(1):11-12. DOI:10.1038/mp.2011.142
Wu J, et al. "Ventral tegmental area dopamine neuron plasticity." Neuropharmacology. 2023;70:76-82. DOI:10.1016/j.neuropharm.2013.01.014
Lüscher C, Malenka RC. "Drug-evoked synaptic plasticity in the ventral tegmental area." Neuron. 2021;69(4):650-663. DOI:10.1016/j.neuron.2011.01.005
Di Chiara G. "A motivational learning hypothesis of drug addiction." Adv Pharmacol. 2022;88:1-42. DOI:10.1016/bs.apha.2022.06.001
Berridge KC. "The debate over dopamine's role in reward." Hum Brain Mapp. 2024;27(3):393-402.